Clinical Trial Update: Effects of SQ109 on QTc Interval in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effects of SQ109 on the QTc interval in healthy subjects has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• SQ109 (SQ109)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1 | Status: WITHDRAWN